These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31990219)

  • 1. Holistic development of coal tar lotion by embedding design of experiments (DoE) technique: preclinical investigations.
    Sharma M; Sharma G; Singh B; Dhiman V; Bhadada SK; Katare OP
    Expert Opin Drug Deliv; 2020 Feb; 17(2):255-273. PubMed ID: 31990219
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind, randomised, multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasis.
    Goodfield M; Kownacki S; Berth-Jones J
    J Dermatolog Treat; 2004 Jan; 15(1):14-22. PubMed ID: 14754644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
    Singh P; Gupta S; Abidi A; Krishna A
    J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coal tar in dermatology.
    Roelofzen JH; Aben KK; van der Valk PG; van Houtum JL; van de Kerkhof PC; Kiemeney LA
    J Dermatolog Treat; 2007; 18(6):329-34. PubMed ID: 17852640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate iontophoresis versus coal tar ointment in palmoplantar psoriasis: A pilot study.
    Haseena K; George S; Riyaz N; Sasidharanpillai S; Puthussery PV
    Indian J Dermatol Venereol Leprol; 2017; 83(5):569-573. PubMed ID: 28731017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and cosmetic acceptability of liquor carbonis distillate (coal tar) solution 15% as topical therapy for plaque psoriasis.
    Brouda I; Edison B; Van Cott A; Green BA
    Cutis; 2010 Apr; 85(4):214-20. PubMed ID: 20486463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatological exposure to coal tar and bladder cancer risk: a case-control study.
    Roelofzen JHJ; Aben KKH; Van de Kerkhof PCM; Van der Valk PGM; Kiemeney LALM
    Urol Oncol; 2015 Jan; 33(1):20.e19-20.e22. PubMed ID: 24629496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observer-blind, randomized, intrapatient comparison of a novel 1% coal tar preparation (Exorex) and calcipotriol cream in the treatment of plaque type psoriasis.
    Tzaneva S; Hönigsmann H; Tanew A
    Br J Dermatol; 2003 Aug; 149(2):350-3. PubMed ID: 12932242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis.
    Kerdel FA; Draelos ZD; Tyring SK; Lin T; Pillai R
    J Dermatolog Treat; 2019 Jun; 30(4):333-339. PubMed ID: 30207807
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar.
    Arbiser JL; Govindarajan B; Battle TE; Lynch R; Frank DA; Ushio-Fukai M; Perry BN; Stern DF; Bowden GT; Liu A; Klein E; Kolodziejski PJ; Eissa NT; Hossain CF; Nagle DG
    J Invest Dermatol; 2006 Jun; 126(6):1396-402. PubMed ID: 16614726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis.
    Tham SN; Lun KC; Cheong WK
    Br J Dermatol; 1994 Nov; 131(5):673-7. PubMed ID: 7999599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a new coal tar preparation in the treatment of chronic plaque-type psoriasis.
    Langner A; Wolska H; Fraczykowska M
    Br J Clin Pract; 1989 Apr; 43(4):148-50. PubMed ID: 2590625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tazarotene vs. coal tar in stable plaque psoriasis.
    Kumar U; Kaur I; Dogra S; De D; Kumar B
    Clin Exp Dermatol; 2010 Jul; 35(5):482-6. PubMed ID: 19874376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis.
    Smith CH; Jackson K; Chinn S; Angus K; Barker JN
    Clin Exp Dermatol; 2000 Nov; 25(8):580-3. PubMed ID: 11167965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited benefit of combined use of tar-based shampoo with 50 microg/ml calcipotriol solution in scalp psoriasis.
    Barrett C; Lowson D; Blades KJ;
    J Dermatolog Treat; 2005 Aug; 16(3):175. PubMed ID: 16211775
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis.
    Khandpur S; Sharma VK
    Clin Exp Dermatol; 2011 Aug; 36(6):613-6. PubMed ID: 21507036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials.
    Lebwohl MG; Sugarman JL; Stein Gold L; Lin T; Israel R
    J Drugs Dermatol; 2019 Oct; 18(10):1012-1018. PubMed ID: 31584780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower Extremities.
    Bhatia ND; Vlahovic TC; Green LG; Martin G; Lin T
    J Drugs Dermatol; 2019 Oct; 18(10):1029-1036. PubMed ID: 31584782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis symposium. Topical therapy.
    Menter A
    Semin Dermatol; 1992 Dec; 11(4 Suppl 1):5-10. PubMed ID: 1337263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.